THE Therapeutic Goods Administration has established a "listed medicine compliance rating scheme" in consultation with peak industry and consumer representative bodies, as part of its existing compliance review process.
Following a transition period of six months, the TGA will begin to publish the ratings assigned to individual medicines under the scheme alongside overall outcomes of each review on the TGA website.
The scheme standardises how the TGA rates listed medicines reviewed in terms of any non-compliance with regulatory requirements and the associated risks to consumers.
The approach aims to boost transparency about the safety and efficacy of self-selected medicines.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Nov 18
